Bristol-Myers Squibb Company Co (NYSE:BMY).
Shares of Bristol-Myers Squibb Company Co (NYSE:BMY) reached a new 52 week low point reaching $54.93 in trading on Wednesday. Shares ended down 1.13% ending the day at $55.11. 11,562,809 shares traded and the stock hit an intraday high of $55.81.
The company recently announced a dividend for shareholders that will be paid on Tue Nov 1, 2016. The dividend will be $0.380 per share for the quarter or $1.52 annualized. This dividend amount will represent a yeild of $2.69. The ex-dividend date will be on Wednesday June 29th, 2016.
Shares finished up at $55.11 just below the 50 day moving average which is $57.62 and which is just under the 200 day moving average of $67.32. The 50 day moving average was down $-2.51 and the 200 day average went down by -18.13%.
Bristol-Myers Squibb Company Co’s P/E ratio is 32.23 and the market value is 92.08B. In the last earnings report the EPS was $1.71 and is estimated to be $2.62 for the current year with 1,670,858,000 shares currently outstanding. Analysts expect next quarter’s EPS will be $0.56 with next year’s EPS anticipated to be $3.00.
Several ratings analysts have provided guidance. On September 12 Jefferies kept the company rating at “Equal-weight” and lowered the price target from $80.00 to $65.00. September 9 investment analysts at Barclays held the stock rating at “Equal-weight” but lowered the price target to $65.00 from $70.00.
On August 19 UBS maintained a stock rating of “Buy” and moved down the price target to $70.00 from $75.00. July 14 investment analysts at Jefferies held the company rating at “Hold” and raised the price expectation from $78.00 to $80.00.
On June 14 Jefferies kept the stock rating at “Hold” but raised the price expectation to $78.00 from $65.00. On April 6 analysts at Societe Generale started covering BMY by announcing an initial rating of “Sell”.